HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy. (Q54600558)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16715132

HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16715132

1 reference

based on heuristic

inferred from title

angiogenesis inhibitor

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16715132

author name string

X-F Wen

1

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16715132

G Yang

2

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16715132

W Mao

3

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16715132

A Thornton

4

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16715132

J Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16715132

X-F Le

7

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16715132

language of work or name

0 references

publication date

22 May 2006

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16715132

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16715132

25

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16715132

52

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16715132

6986-6996

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16715132

Vascular endothelial growth factor up-regulation via p21-activated kinase-1 signaling regulates heregulin-beta1-mediated angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Future options with trastuzumab for primary systemic and adjuvant therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

p38 MAP kinase's emerging role as a tumor suppressor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Different signalling pathways regulate VEGF and IL-8 expression in breast cancer: implications for therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Platinum-taxane combinations in metastatic breast cancer: an evolving role in the era of molecularly targeted therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Vascular endothelial growth factor (VEGF), a survival factor for tumour cells: implications for anti-angiogenic therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

VEGF-Trap: a VEGF blocker with potent antitumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

ErbB receptors: directing key signaling networks throughout life

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Tumour biology: herceptin acts as an anti-angiogenic cocktail.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Combined trastuzumab and paclitaxel treatment better inhibits ErbB-2-mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

The role of HER2 in angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

The role of cyclin-dependent kinase inhibitor p27Kip1 in anti-HER2 antibody-induced G1 cell cycle arrest and tumor growth inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Genes affecting the cell cycle, growth, maintenance, and drug sensitivity are preferentially regulated by anti-HER2 antibody through phosphatidylinositol 3-kinase-AKT signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

ErbB2 overexpression in mammary cells upregulates VEGF through the core promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Signal transduction and oncogenesis by ErbB/HER receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Human neuroblastoma cells produce extracellular matrix-degrading enzymes, induce endothelial cell proliferation and are angiogenic in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

A comparison of the in vitro and in vivo activities of IgG and F(ab')2 fragments of a mixture of three monoclonal anti-Her-2 antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Smad-dependent GADD45beta expression mediates delayed activation of p38 MAP kinase by TGF-beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2/neu gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Overexpression of ErbB2 in cancer and ErbB2-targeting strategies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Role of interleukin-8 in tumor growth and metastasis of human melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

Akt takes center stage in angiogenesis signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal antibody therapy for breast cancer: herceptin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: Identification of interleukin-8 as a potential regulatory factor in breast tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-β1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/neu protein and vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of thrombospondin-1 in tumor progression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

Bispecific minibodies targeting HER2/neu and CD16 exhibit improved tumor lysis when placed in a divalent tumor antigen binding format

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1209685

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16715132

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16715132

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54600558&oldid=2212534057"